The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China
Cancer Medicine · 2023-02 · 12 (4) · 4852-4863
DOI: 10.1002/cam4.5307 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Medicine, online erschienen am 10.10.2022. Verfasst von Runhua Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Prevention/Zhejiang Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus), The Cancer H…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Esophageal cancer (EC) often occurs in the elderly, and approximately 40% of patients are 70 years or older. To investigate the long‐term survival of EC in elderly patients, to provide a theoretical direction for better management and predicting survival of EC based on the hospital‐based multi‐center study in China.
Methods
The study was conducted in 18 hospitals including 6 provincial hospitals, 8 municipal hospitals, and 4 county hospitals. We extracted information from medical record homepage, records of admission and discharge, and pathological diagnosis reports from the medical record department of the elderly patients at 70–84 years old to obtain the 3‐year and 5‐year overall survival (OS), and main associated factors, and to analyze the current therapeutic effect of different treatment options for elderly patients.
Results
The 3‐year and 5‐year OS rate of the 1013 elderly patients was 44.8% and 32.8%, respectively. Their median survival was 28.00 months. The median survival of patients with squamous cell carcinoma was longer than that of other pathological type (squamous vs. other types: 31.00 vs. 20.00 months, p = 0.018). The median survival of patients with surgery only or combined therapy was longer than that of radiotherapy, chemotherapy, and no therapy (surgery only vs. combined therapy vs. radiotherapy vs. chemotherapy vs. no therapy: 56.00 vs. 33.00 vs. 26.00 vs.18.00 vs. 16.00 months, p < 0.001). The 5‐year OS rate of patients with highly differentiated cancer was higher than that of medium differentiated and poor differentiation/undifferentiated. In multivariate analysis, the older ages, pathological stage, were independent prognostic risk factors for poor EC survival. Treatment method was independent protective factors predictive of a good EC OS.
Conclusions
The survival rate of the elderly EC patients was still low in China. Age, therapy method, and pathological stage were mainly associated with the survival rate of EC in elderly patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cancer Prevention/Zhejiang Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus), The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Can…
- Cancer Institute, The Fourth Hospital of Hebei Medical University/The Tumor Hospital of Hebei Province, Shijiazhuang, Hebei, China.
- Henan Cancer Hospital, Zhengzhou, Henan, China.
- Peking University Cancer Hospital (Beijing Cancer Hospital), Beijing, China.
- Hubei Cancer Hospital, Wuhan, Hubei, China.
- Cancer Institute, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.
ORCID-Profile: Runhua Li, Xibin Sun, Kuangrong Wei, Lingbin Du, Wanqing Chen
Zitieren
APA
Li, R., He, Y., Sun, X., Wang, N., Zhang, M., Wei, K., Li, H., Dong, P., Du, L., & Chen, W. (2023). The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China. Cancer Medicine, 12(4), 4852-4863. https://doi.org/10.1002/cam4.5307
Vancouver
Li R, He Y, Sun X, Wang N, Zhang M, Wei K, et al. The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China. Cancer Medicine. 2023;12(4):4852-4863. doi:10.1002/cam4.5307
BibTeX
@article{Li2023,
author = {Li, Runhua and He, Yutong and Sun, Xibin and Wang, Ning and Zhang, Min and Wei, Kuangrong and Li, Huizhang and Dong, Peng and Du, Lingbin and Chen, Wanqing},
title = {The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {4},
pages = {4852--4863},
doi = {10.1002/cam4.5307}
}
EUVIMED